Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

Disparity in the Use of Allo HSCT in AML - Benefit of Allo Transplant in Older vs. Young Adults & Overview of SIERRA Trial (Iomab-B + HCT)

104 views
July 19, 2019
Comments 0
Login to view comments. Click here to Login